From mechanical triggering to metabolic-inflammatory driving: a new paradigm of knee osteoarthritis pathogenesis - Report - MDSpire

From mechanical triggering to metabolic-inflammatory driving: a new paradigm of knee osteoarthritis pathogenesis

  • By

  • Manli Yan

  • Xin Zhang

  • Hao Liu

  • Qingyang Kang

  • Jianjiang Li

  • Baoqing Zhang

  • Dingkun Lin

  • Xiang Li

  • May 18, 2026

  • 0 min

Share

Clinical Report: Shifting Perspectives on Knee Osteoarthritis

Overview

Revise to emphasize the interplay between mechanical, metabolic, and inflammatory factors.

Background

Knee osteoarthritis is a leading cause of disability globally, affecting millions and imposing significant socioeconomic burdens. Traditionally viewed as a mechanical wear-and-tear process, recent insights reveal that metabolic and inflammatory factors play crucial roles in disease progression. Understanding these mechanisms is vital for developing effective prevention and treatment strategies.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

  • KOA is characterized by a triad of cartilage degradation, subchondral bone remodeling, and synovial inflammation.
  • Mechanical loading initiates joint damage, but systemic metabolic dysfunction and chronic inflammation drive disease progression.
  • Obesity may act as a pathophysiological bridge, linking metabolic factors to local joint inflammation.
  • Emerging research highlights the role of lipid metabolism and adipokines in chondrocyte senescence and KOA progression.
  • Synovial fluid metabolomics is being explored for potential biomarkers in KOA.

Clinical Implications

Clinicians should consider a comprehensive approach to KOA management that includes addressing metabolic and inflammatory factors, rather than focusing solely on mechanical symptoms. This may involve targeted nutritional interventions and metabolic-modulating therapies to improve patient outcomes.

Conclusion

The evolving understanding of KOA underscores the need for integrated treatment strategies that address both mechanical and metabolic-inflammation pathways, paving the way for innovative therapeutic approaches.

Related Resources & Content

  1. Knee Surgery, Sports Traumatology, Arthroscopy, 2011 -- Biomechanical Factors Influencing the Development of Knee Osteoarthritis
  2. Clinical Rheumatology, 2020 -- Is Metabolic Profiling a Key to Understanding Osteoarthritis and Advancing Personalized Medicine?
  3. Clinical Rheumatology, 2025 -- Association between the systemic immune-inflammation index and risk of osteoarthritis: a cross-sectional NHANES 2013–2018 study
  4. Frontiers in Immunology, 2026 -- Unlocking the potential of engineered exosomes for knee osteoarthritis therapy
  5. AAOS Guidelines, 2021 -- Non-Arthroplasty Clinical Practice Guideline
  6. JAMA Network, 2025 -- Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial
  7. https://new.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/oak3cpg.pdf
  8. Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial | Trials | JAMA | JAMA Network
  9. Neuromuscular exercise in addition to celecoxib versus celecoxib alone for symptomatic and radiographic knee osteoarthritis: a randomized controlled trial | BMC Sports Science, Medicine and Rehabilitation | Springer Nature Link

Original Source(s)

Related Content